New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 8, 2013
12:19 EDTVRX, WFT, LUFK, OMPI, FTK, JNJ, BCRX, GEOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday as investors await the start of the latest earnings season, which kicks off unofficially after today's close with Alcoa's (AA) report. The averages all fell into negative ground soon after the open and found a level, from which they have been range-bound ever since. With a very quiet economic calendar today and generally depressed expectations for the earnings seasons, the lackluster trading may extend from here until the close... ECONOMIC EVENTS: In the U.S., no major economic data was reported... COMPANY NEWS: General Electric (GE) agreed to acquire Lufkin (LUFK), which supplies products, technology and services to the oil and gas industry, for $3.3B, or $88.50 per share in cash. Lufkin soared over 37% to trade within 50c of the agreed upon per share price at midday, while some of its peers rose as well, including Flotek (FTK) and Weatherford (WFT), which both advanced over 3%. GE shares, meanwhile, slid 0.4%... MAJOR MOVERS: Among the notable gainers was BioCryst (BCRX), which rose 22% amid reports of new bird flu infections in China. BioCryst is developing peramivir, an investigational anti-viral agent to treat influenza. Among the noteworthy losers was Obagi Medical (OMPI), which fell 6% after Merz Pharma withdrew its offer to acquire Obagi in the face of a $24 per share competing offer from Valeant Pharmaceuticals (VRX). Also lower were shares of Johnson & Johnson (JNJ), which slid nearly 2% after JPMorgan lowered it rating on the stock to Neutral from Overweight... INDICES: Near noon, the Dow was down 51.84, or 0.36%, to 14,513.41; the Nasdaq was down 3.11, or 0.10%, to 3,200.75; and the S&P 500 was down 1.63, or 0.10%, to 1,551.65.
News For LUFK;GE;FTK;WFT;BCRX;OMPI;VRX;JNJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 13, 2014
07:23 EDTVRXValeant wooing doctors ahead of hoped for Allergan acquisition, WSJ says
Subscribe for More Information
November 12, 2014
10:09 EDTVRXActavis in talks to buy Allergan for over $200 per share, Bloomberg says
Subscribe for More Information
09:01 EDTGEGE to build advanced manufacturing facility in Pennsylvania
GE announced that it will build a new manufacturing facility to drive innovation and implementation of advanced manufacturing technologies across GE. The new facility represents a $32M investment over three years by the company and will result in the creation of 50 high-tech engineering jobs initially, in disciplines ranging from mechanical and electrical to systems and software engineering. These technologists will join GE’s global network of 50,000 world-class scientists, engineers, and skilled labor who are working to solve some of the world’s toughest challenges. The new facility reflects GE’s belief that the intersection of technology and manufacturing – marrying hardware with software – is bringing a new era of manufacturing. The site will be located outside of Pittsburgh in Findlay Township, PA to capitalize on the renowned academic institutions and skilled workforce in the area. Construction is expected to begin in March 2015 to be completed by September 2015.
08:05 EDTGEGoldman to hold a conference
Subscribe for More Information
07:59 EDTWFTMitsubishi UFJ to hold a tour
Subscribe for More Information
06:22 EDTVRXZoetis price target raised to $49 from $44 at Citigroup
Citigroup raised its price target for Zoetis (ZTS) shares to $49 after activist Pershing Square confirmed the accumulation of a 10% stake in the company. Citi thinks Pershing is interested in advocating for a sale of Zoetis, potentially to Valeant (VRX) if its bid for Allergan (AGN) fails. Citi believes others, including Bayer (BAYRY), could be interested in acquiring Zoetis. It keeps a Buy rating on the stock.
November 11, 2014
16:24 EDTVRXOn The Fly: Closing Wrap
Subscribe for More Information
15:46 EDTVRXPershing Square, Sachem Head build 10% stake in Zoetis, WSJ reports
Subscribe for More Information
08:32 EDTVRXValeant likely to raise offer for Allergan again, says Bernstein
Subscribe for More Information
08:01 EDTGEGE Healthcare, Takeda enter into alliance agreement for R&D in hepatic fibrosis
Subscribe for More Information
November 10, 2014
07:44 EDTJNJJohnson & Johnson looks for acquisitions to help expand in China, WSJ says
Subscribe for More Information
06:30 EDTGEGlobal LED lighting market ste to rach $25.7B in 2014, DigiTimes says
Subscribe for More Information
November 9, 2014
13:26 EDTVRXAckman's Allergan court win may prove costly down the road, Bloomberg says
When U.S. District Court Judge David Carter ruled on November 4 that Pershing Square can vote its 9.7% stake in Allergan (AGN) in a shareholder ballot aiming to remove Allergan directors, he also noted that there were “serious questions” regarding insider trading rules in the way Pershing Square acquired Allergan stock while preparing a bid with Valeant (VRX), says Bloomberg. Reference Link
November 7, 2014
17:05 EDTVRXValeant sends open letter to physician customers
Subscribe for More Information
16:53 EDTGEGeneral Electric files to sell 75M shares of common stock
Subscribe for More Information
16:07 EDTJNJJohnson & Johnson completes acquisition of Alios BioPharma
Subscribe for More Information
14:56 EDTVRXAllergan says Valeant offers to date inadequate, would consider increased bid
Subscribe for More Information
09:49 EDTVRXAckman says Allergan 'tipping scales' in Actavis’ favor, disadvantaging Valeant
Subscribe for More Information
08:09 EDTBCRXDyax in great position after competitor's changes, says RBC Capital
Subscribe for More Information
07:04 EDTGESouthcross Energy Partners completes $210M capital commitment
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use